Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
FOR IMMEDIATE RELEASE –November 06,2026 – East Windsor, New Jersey, Eugia US LLC (f/k/a Auro Medics Pharma LLC) is voluntarily recalling lot number…
Vitality Works Inc.
CGMP Deviations
Presence of Foreign Tablets/Capsules
Failed Impurities/Degradation Specification
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the…
FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 13, 2026 – Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the…
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the…
Lack of sterility assurance.
Labeling: Not Elsewhere Classified
Lack of Assurance of Sterility
Labeling: Label Lacks Warning or Rx Legend
Lack of Assurance of Sterility
Labeling: Label Lacks Warning or Rx Legend
FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV…
Failed dissolution specifications
Failed Dissolution Specifications.
Presence of Foreign Tablets/Capsules
Manufacturer is recalling batches due to co-mingled tablet.
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.